Indian F&O data, and the evidence about what not to trade · educational
LAURUSLABS · Healthcare
1M / 3M / 1Y
+5.0% / +40.0% / +108.9%
Traded value (60d med)
₹300 cr
Days in F&O ban since 2020
0
Futures OI / 1d change
17.5M / -0.8M
ATM implied vol
24% (vs 29% realized)
📜 Results-day history
Typical move 3.0% · up on the day 44% of 27 events · moved 4%+ in 37% · worst -11.3% / best +18.1%
| Reaction day | Move | Open gap | Next 5d | Announced |
|---|
| 2026-07-17 | -1.8% | +0.2% | +4.7% | after close |
| 2026-04-23 | +3.0% | +0.0% | -2.5% | after close |
| 2026-01-21 | -4.6% | -0.2% | +1.1% | after close |
| 2025-10-20 | +2.3% | +0.3% | +2.1% | after close |
| 2025-07-23 | -0.1% | +0.2% | +7.2% | after close |
| 2025-04-17 | +0.2% | -0.0% | -0.4% | after close |
| 2025-01-27 | -11.3% | +1.2% | +9.7% | after close |
| 2024-10-25 | +4.1% | -1.0% | +7.3% | after close |
Educational data reference: NOT investment advice. Historical statistics do not predict future results. We are not SEBI-registered advisers. All data from NSE public sources; figures may contain errors. Trading, especially leveraged F&O, can cause significant losses.